Chronic Neurology in COVID-19 Era: Clinical Considerations and Recommendations From the REPROGRAM Consortium.

chronic neurological disease coronavirus disease 2019 (COVID-19) guidelines healthcare services neurodegenerative disorders pandemics protocols recommendations

Journal

Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899

Informations de publication

Date de publication:
2020
Historique:
received: 30 04 2020
accepted: 03 06 2020
entrez: 23 7 2020
pubmed: 23 7 2020
medline: 23 7 2020
Statut: epublish

Résumé

With the rapid pace and scale of the emerging coronavirus 2019 (COVID-19) pandemic, a growing body of evidence has shown a strong association of COVID-19 with pre- and post- neurological complications. This has necessitated the need to incorporate targeted neurological care for this subgroup of patients which warrants further reorganization of services, healthcare workforce, and ongoing management of chronic neurological cases. The social distancing and the shutdown imposed by several nations in the midst of COVID-19 have severely impacted the ongoing care, access and support of patients with chronic neurological conditions such as Multiple Sclerosis, Epilepsy, Neuromuscular Disorders, Migraine, Dementia, and Parkinson disease. There is a pressing need for governing bodies including national and international professional associations, health ministries and health institutions to harmonize policies, guidelines, and recommendations relating to the management of chronic neurological conditions. These harmonized guidelines should ensure patient continuity across the spectrum of hospital and community care including the well-being, safety, and mental health of the patients, their care partners and the health professionals involved. This article provides an in-depth analysis of the impact of COVID-19 on chronic neurological conditions and specific recommendations to minimize the potential harm to those at high risk.

Identifiants

pubmed: 32695066
doi: 10.3389/fneur.2020.00664
pmc: PMC7339863
doi:

Types de publication

Journal Article

Langues

eng

Pagination

664

Informations de copyright

Copyright © 2020 Bhaskar, Bradley, Israeli-Korn, Menon, Chattu, Thomas, Chawla, Kumar, Prandi, Ray, Golla, Surya, Yang, Martinez, Ozgen, Codrington, González, Toosi, Hariya Mohan, Menon, Chahidi and Mederer Hengstl.

Références

Neurology. 2020 Jun 2;94(22):949-952
pubmed: 32241953
Neurol Sci. 2020 Jun;41(6):1351-1354
pubmed: 32399950
J Neurol. 2020 Aug;267(8):2196-2197
pubmed: 32458198
Eur Arch Otorhinolaryngol. 2020 Aug;277(8):2251-2261
pubmed: 32253535
SN Compr Clin Med. 2020 Apr 1;:1-2
pubmed: 32292883
Neurology. 2020 Apr 17;:
pubmed: 32303650
J Headache Pain. 2020 Apr 25;21(1):38
pubmed: 32334535
J Formos Med Assoc. 2020 Jun;119(6):1119-1120
pubmed: 32354690
SN Compr Clin Med. 2020 Apr 8;:1-2
pubmed: 32292884
Nat Microbiol. 2020 Apr;5(4):536-544
pubmed: 32123347
Clin Med Res. 2003 Jan;1(1):57-60
pubmed: 15931287
J Infect. 2020 Jun;80(6):639-645
pubmed: 32240670
J Neurol Sci. 2020 Jul 15;414:116884
pubmed: 32464367
J Med Virol. 2020 Jun;92(6):552-555
pubmed: 32104915
JACC Heart Fail. 2015 Aug;3(8):647-53
pubmed: 26251094
Epilepsia. 2020 Jun;61(6):e49-e53
pubmed: 32304092
BMJ. 2020 Mar 27;368:m1185
pubmed: 32220865
Am J Cardiol. 1987 May 15;59(13):26F-32F
pubmed: 2883874
J Korean Med Sci. 2020 May 11;35(18):e174
pubmed: 32383370
Neurology. 2020 May 12;94(19):809-810
pubmed: 32229625
Lancet Psychiatry. 2020 Jun;7(6):e29-e30
pubmed: 32445691
Radiology. 2020 Aug;296(2):E119-E120
pubmed: 32228363
Headache. 2018 Jan;58(1):173-183
pubmed: 28181217
JAMA Neurol. 2020 May 29;:
pubmed: 32469387
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Lancet Respir Med. 2020 May;8(5):e28
pubmed: 32222168
J Parkinsons Dis. 2020;10(2):351-354
pubmed: 32250324
Front Neurol. 2020 May 29;11:579
pubmed: 32574252
Intern Med J. 2019 Nov 24;:
pubmed: 31760675
Crit Care. 2020 Apr 28;24(1):176
pubmed: 32345343
Front Cardiovasc Med. 2020 Jun 16;7:112
pubmed: 32613010
Laryngoscope. 2020 Jul;130(7):1787
pubmed: 32237238
N Z Med J. 2020 Apr 3;133(1512):85-87
pubmed: 32242182
Lancet Psychiatry. 2020 Jul;7(7):611-627
pubmed: 32437679
BMJ Case Rep. 2019 May 15;12(5):
pubmed: 31092485
N Engl J Med. 2020 Jun 25;382(26):2574-2576
pubmed: 32302082
Cephalalgia. 2019 Oct;39(12):1577-1585
pubmed: 31450969
Lancet. 2020 Apr 11;395(10231):1190-1191
pubmed: 32240625
Lancet Neurol. 2020 May;19(5):383-384
pubmed: 32246917
PLoS One. 2012;7(4):e35797
pubmed: 22563403
Headache. 2020 Mar;60(3):649-653
pubmed: 31967337
J Neurol Sci. 2020 May 15;412:116803
pubmed: 32247193
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
JAMA Neurol. 2020 Apr 10;:
pubmed: 32275288
J Peripher Nerv Syst. 2020 Jun;25(2):204-207
pubmed: 32388880
J Clin Neurosci. 2020 Jun;76:233-235
pubmed: 32312628
Cochrane Database Syst Rev. 2013 Apr 30;(4):CD008040
pubmed: 23633349
Acta Neurol Taiwan. 2005 Sep;14(3):113-9
pubmed: 16252612
Int Rev Neurobiol. 2017;133:541-556
pubmed: 28802932
Emerg Infect Dis. 2020 Jul;26(7):1618-1620
pubmed: 32197060
Intervirology. 2016;59(3):163-169
pubmed: 28103598
Telemed J E Health. 2020 Apr;26(4):377-379
pubmed: 32202977
Lancet. 2019 Feb 16;393(10172):689-701
pubmed: 30686584
N Engl J Med. 2020 May 14;382(20):e60
pubmed: 32343504
Mult Scler Relat Disord. 2020 Apr;39:102073
pubmed: 32334820
Stroke. 2020 Jun;51(6):1891-1895
pubmed: 32233980
EBioMedicine. 2016 Apr;6:14-15
pubmed: 27211537
Am J Geriatr Psychiatry. 2020 Jul;28(7):712-721
pubmed: 32331845
Neuroepidemiology. 2015;44(1):64-5
pubmed: 25721315

Auteurs

Sonu Bhaskar (S)

Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, Chronic Neurology REPROGRAM Sub-committee†.
Department of Neurology and Neurophysiology, Liverpool Hospital, Sydney, NSW, Australia.
Neurovascular Imaging Laboratory & NSW Brain Clot Bank, Ingham Institute for Applied Medical Research and South West Sydney Clinical School, The University of New South Wales, UNSW Medicine, Sydney, NSW, Australia.

Sian Bradley (S)

Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, Chronic Neurology REPROGRAM Sub-committee†.
The University of New South Wales, UNSW Medicine, Sydney, NSW, Australia.

Simon Israeli-Korn (S)

Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, Chronic Neurology REPROGRAM Sub-committee†.
Department of Neurology, Sheba Medical Center, Tel Hashomer, Ramat Gan and Sackler School of Medicine, Movement Disorders Institute, Tel Aviv University, Tel Aviv-Yafo, Israel.

Bindu Menon (B)

Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, Chronic Neurology REPROGRAM Sub-committee†.
Department of Neurology, Apollo Hospitals, Nellore, India.

Vijay Kumar Chattu (VK)

Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, Chronic Neurology REPROGRAM Sub-committee†.
Department of Medicine, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada.

Pravin Thomas (P)

Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, Chronic Neurology REPROGRAM Sub-committee†.
Department of Neurology, University Hospitals NHS Foundation Trust, Birmingham, United Kingdom.

Jasvinder Chawla (J)

Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, Chronic Neurology REPROGRAM Sub-committee†.
Department of Neurology, Loyola University Medical Center & Hines VA Hospital, Chicago, IL, United States.

Rajeev Kumar (R)

Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, Chronic Neurology REPROGRAM Sub-committee†.
Department of Psychiatry, Hamad Medical Center, Qatar & Australian National University, Canberra, ACT, Australia.

Paolo Prandi (P)

Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, Chronic Neurology REPROGRAM Sub-committee†.
Department of Neurology, University of Eastern Piedmont Amedeo Avogadro, Novara, Italy.

Daniel Ray (D)

Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, Chronic Neurology REPROGRAM Sub-committee†.
Farr Institute of Health Informatics, University College London (UCL) & NHS Foundation Trust, Birmingham, United Kingdom.

Sailaja Golla (S)

Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, Chronic Neurology REPROGRAM Sub-committee†.
Texas Institute for Neurological Disorders, Dallas, TX, United States.

Nirmal Surya (N)

Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, Chronic Neurology REPROGRAM Sub-committee†.
Department of Neurology, Bombay Hospital & Medical Research Centre, and Epilepsy Foundation India, Mumbai, India.

Harvey Yang (H)

Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, Chronic Neurology REPROGRAM Sub-committee†.
Department of Neurology, Academic Hospital Paramaribo & Anton de Kom Universiteit van Suriname Faculteit der Medische Wetenschappen, Paramaribo, Suriname.

Sandra Martinez (S)

Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, Chronic Neurology REPROGRAM Sub-committee†.
Department of Neurology, Hospital da Restauração, Recife, Brazil.

Mihriban Heval Ozgen (MH)

Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, Chronic Neurology REPROGRAM Sub-committee†.
Department of Psychiatry, Parnassia Psychiatric Institute, The Hague, Netherlands.
Curium-Leiden University Medical Centre, Oegstgeest, Netherlands.

John Codrington (J)

Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, Chronic Neurology REPROGRAM Sub-committee†.
Department of Laboratory Medicine, Academic Hospital Paramaribo and Anton de Kom Universiteit van Suriname Faculteit der Medische Wetenschappen, Paramaribo, Suriname.

Eva María Jiménez González (EMJ)

Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, Chronic Neurology REPROGRAM Sub-committee†.
Department of Forensic Psychology, Forensic Psychology and Forensic Sciences Institute, Ministry of Justice, Granada, Spain.

Mandana Toosi (M)

Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, Chronic Neurology REPROGRAM Sub-committee†.
LodeStone Center for Behavioral Health and Eastern Illinois University, Chicago, IL, United States.

Nithya Hariya Mohan (N)

Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, Chronic Neurology REPROGRAM Sub-committee†.
Chengalpattu Medical College and Hospital, Chengalpattu, India.

Koravangattu Valsraj Menon (KV)

Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, Chronic Neurology REPROGRAM Sub-committee†.
Department of Psychiatry, South London and Maudsley NHS Foundation Trust, Kings Health Partners, London, United Kingdom.

Abderrahmane Chahidi (A)

Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, Chronic Neurology REPROGRAM Sub-committee†.
ED 268, DR 178, Sorbonne Nouvelle University, Paris, France.
Moroccan Society of Neurophysiology, Marrakech, Morocco.
Morocco and Basic and Clinical Neurosciences Research Laboratory, University Medical School of Marrakech, Marrakech, Morocco.

Susana Mederer Hengstl (S)

Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, Chronic Neurology REPROGRAM Sub-committee†.
Department of Neurology, Complejo Hospitalario de Pontevedra, Pontevedra, Spain.

Classifications MeSH